Skip Prichard

JULY 22, 2019

It’s a fascinating study, one that echoes my constant inquiry of the difference between success and failure. You are teaching what separates successful innovators from those who struggle. If Tesla’s ideas ultimately had more impact, then why was Edison so much more successful? Lessons from Tesla versus Edison.

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

FEBRUARY 22, 2013

Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. By 2010, sales exceeded $2B.

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MARCH 1, 2011

And biotechnology and medical devices are among the leading areas for venture capital funding. Very few things in the economy are the same today as they were a half century ago, and most of those are still the same are not considered successes. Will hospital managers search for efficiency, or continue to manage volume?

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15